Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
25.74
+0.03 (+0.12%)
Official Closing Price
Updated: 5:00 PM EST, Nov 28, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
39
40
Next >
Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)
November 24, 2025
From
Arvinas Inc.
Via
GlobeNewswire
U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
November 21, 2025
From
Pfizer Inc.
Via
Business Wire
Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For
November 20, 2025
From
BioMedWire
Via
GlobeNewswire
Pfizer Completes Acquisition of Metsera
November 13, 2025
From
Pfizer Inc.
Via
Business Wire
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
November 12, 2025
From
Pfizer Inc.
Via
Business Wire
Global Virtual Summit Puts the Spotlight on Sickle Cell Caregivers
November 08, 2025
November 8, 2025 -- Four-Day Event Unites Families, Advocates, and Medical Experts to Prioritize Mental Wellness, Advocacy, and Legacy
Via
24-7 Press Release
Pfizer Responds to Delaware Chancery Court Ruling
November 05, 2025
From
Pfizer Inc.
Via
Business Wire
Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance
November 04, 2025
From
Pfizer Inc.
Via
Business Wire
Pfizer Files Federal Antitrust Claims in Second Lawsuit Against Metsera, its Controlling Stockholders and Novo Nordisk
November 03, 2025
From
Pfizer Inc.
Via
Business Wire
Pfizer Files Lawsuit Against Metsera and its Directors and Novo Nordisk for Breach of Merger Agreement
October 31, 2025
From
Pfizer Inc.
Via
Business Wire
Pfizer Receives Early Clearance from U.S. Federal Trade Commission for Metsera Acquisition
October 31, 2025
From
Pfizer Inc.
Via
Business Wire
Pfizer Addresses Proposal for Metsera
October 30, 2025
From
Pfizer Inc.
Via
Business Wire
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
October 27, 2025
Via
Investor Brand Network
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
October 27, 2025
EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOBT),(NYSE:NVS),(NASDAQ:BCAX),(NYSE:PFE) EQNX::TICKER_END
Via
FinancialNewsMedia
Nikki Barjon Ushers in a New Era of Branding and Legacy Building
October 23, 2025
Via
Press Release Distribution Service
Patient-Reported Outcomes from VERITAC-2 Clinical Trial Support Clinical Benefit of Vepdegestrant in Patients with ESR1-Mutated, ER+/HER2- Advanced or Metastatic Breast Cancer Previously Treated with Endocrine-Based Therapy
October 20, 2025
From
Arvinas Inc.
Via
GlobeNewswire
Pfizer’s BRAFTOVI® + MEKTOVI® Shows Sustained Long-Term Survival in Patients with Advanced Lung Cancer
October 19, 2025
From
Pfizer Inc.
Via
Business Wire
XTANDI® Plus Leuprolide Reduced Risk of Death by 40% vs Leuprolide Alone in Men with a Type of Advanced Prostate Cancer
October 19, 2025
From
Pfizer Inc.
Via
Business Wire
TUKYSA Combination Significantly Improves Progression-Free Survival as First-Line Maintenance in HER2+ Metastatic Breast Cancer in HER2CLIMB-05 Trial
October 14, 2025
From
Pfizer Inc.
Via
Business Wire
Pfizer to Highlight Advancements in Respiratory Health and Infectious Disease Research at IDWeek 2025
October 13, 2025
From
Pfizer Inc.
Via
Business Wire
Pfizer Declares Fourth-Quarter 2025 Dividend
October 09, 2025
From
Pfizer Inc.
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Premier, Inc. (Nasdaq – PINC), Metsera, Inc. (Nasdaq – MTSR), Anywhere Real Estate Inc. (NYSE – HOUS), The ODP Corporation (Nasdaq – ODP)
October 07, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients
September 30, 2025
From
Pfizer Inc.
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Premier, Inc. (Nasdaq – PINC), Metsera, Inc. (Nasdaq – MTSR), Anywhere Real Estate Inc. (NYSE – HOUS), The ODP Corporation (Nasdaq – ODP)
September 29, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
Digital Pharma Advances 2026: AI and Patient-Centric Strategies Transform Pharma Marketing
September 29, 2025
Via
PRLog
Topics
Artificial Intelligence
Hearing Against Pfizer Set For 29 September In Contraceptive ‘Depo-Provera’ Multidistrict Litigation Overseen By Levin Papantonio
September 25, 2025
From
Levin Papantonio
Via
Business Wire
Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025
September 25, 2025
From
Pfizer Inc.
Via
Business Wire
Pfizer Invites Public to View and Listen to Webcast of November 4 Conference Call with Analysts
September 23, 2025
From
Pfizer Inc.
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Premier, Inc. (Nasdaq – PINC), Metsera, Inc. (Nasdaq – MTSR), Anywhere Real Estate Inc. (NYSE – HOUS), The ODP Corporation (Nasdaq – ODP)
September 22, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio
September 22, 2025
From
Pfizer Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
39
40
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
